Diagnosis and treatment of the Ehlers-Danlos syndromes in China: synopsis of the first guidelines
- PMID: 38741208
- PMCID: PMC11092078
- DOI: 10.1186/s13023-024-03121-0
Diagnosis and treatment of the Ehlers-Danlos syndromes in China: synopsis of the first guidelines
Abstract
Background: The Ehlers-Danlos syndromes (EDS) are a group of rare hereditary connective tissue disorders. EDS is clinically and genetically heterogeneous and usually involves multiple systems. There are 14 subtypes of EDS with hallmark features including joint hypermobility, skin hyperextensibility, and tissue fragility. The clinical manifestations and their severity differ among the subtypes, encompassing recurrent joint dislocations, scoliosis, arterial aneurysm and dissection, and organ rupture. Challenges in diagnosis and management arise from the complexity of the disease, which is further complicated by its rarity. The development of clinical guidelines and implementation of coordinated multi-disciplinary team (MDT) approaches have emerged as global priorities.
Main body: Chinese Multi-Disciplinary Working Group on the Ehlers-Danlos Syndromes was therefore established. Healthcare professionals were recruited from 25 top hospitals across China. The experts are specialized in 24 fields, including genetics, vascular surgery, dermatology, and orthopedics, as well as nursing care, rehabilitation, psychology, and nutrition. Based on GRADE methodology, the Guidelines were written by the Group supervised by methodologists, following a systemic review of all 4453 articles in PubMed published before August 9, 2023, using the search term "Ehlers Danlos". A coordinated MDT approach for the diagnosis and management of EDS is highly recommended by the Group, along with 29 specific recommendations addressing key clinical questions. In addition to the treatment plan, the Guidelines also emphasize integrating support from nursing care, rehabilitation, psychology, and nutrition. This integration not only facilitates recovery in hospital settings, but most importantly, the transition from an illness-defined life to a more "normalized" life.
Conclusion: The first guidelines on EDS will shorten the diagnostic odyssey and solve the unmet medical needs of the patients. This article is a synopsis of the full guidelines.
Keywords: Clinical guidelines; Diagnosis and treatment; Ehlers-Danlos syndromes; Multi-disciplinary team approach.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Ehlers E. Cutis Laxa, Neigung zu Haemorrhagien in Der Haut, lockerung mehrerer artikulationen. Dermat Zachr. 1901;8:173–4.
-
- Danlos H. Un cas de cutin laxa avec tumeus par cantusion chroniguedes coudes et des genoux. Bull de Soc Franc Dematal. 1908;19:70–2.
-
- Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK) Am J Med Genet. 1998;77(1):31–7. doi: 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O. - DOI - PubMed
MeSH terms
Grants and funding
- 2022-PUMCH-D-004/National High Level Hospital Clinical Research Funding
- 2022-PUMCH-C-033/National High Level Hospital Clinical Research Funding
- 2021-I2M-1-051/National Natural Science Foundation of China CAMS Innovation Fund for Medical Sciences
- 2022YFC2703100/National Key Research and Development Program of China
- No. 2019PT320025/Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
LinkOut - more resources
Full Text Sources
Medical
